Stock Performance and Market Context
On 9 December 2025, Deccan Health Care's stock price touched Rs.14.2, the lowest level recorded in the past 52 weeks and also an all-time low. This price point reflects a continuation of the stock's recent trajectory, having declined for four consecutive trading sessions, resulting in a cumulative return of -7.64% during this period. The stock's performance today underperformed the Healthcare Services sector by 0.29%, signalling relative weakness within its industry group.
In comparison, the Sensex opened lower at 84,742.87 points, down by 359.82 points or 0.42%, and was trading near 84,805 points at the time of reporting. Despite this, the Sensex remains close to its 52-week high of 86,159.02, just 1.6% away, supported by bullish moving averages with the 50-day moving average positioned above the 200-day moving average. Small-cap stocks led the market gains, with the BSE Small Cap index rising by 0.37%, contrasting with Deccan Health Care’s underperformance.
Technical Indicators and Moving Averages
Deccan Health Care is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning suggests a persistent bearish momentum in the stock price, with no immediate signs of reversal based on these indicators. The gap between the current price and these averages highlights the stock’s struggle to regain upward traction in the near term.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
Long-Term Performance and Financial Metrics
Over the past year, Deccan Health Care has recorded a total return of -51.63%, a stark contrast to the Sensex’s 4.03% gain during the same period. This underperformance extends beyond the last year, with the stock consistently lagging behind the BSE500 index in each of the previous three annual periods. The 52-week high for the stock was Rs.32.89, underscoring the significant erosion in market value over the last twelve months.
From a fundamental perspective, the company’s average Return on Equity (ROE) stands at 1.43%, indicating modest profitability relative to shareholder equity. Additionally, the company’s ability to cover interest expenses from earnings before interest and taxes (EBIT) is limited, with an average EBIT to interest ratio of 1.84. These metrics reflect constraints in generating robust returns and servicing debt obligations effectively.
Recent Operational and Sales Data
Despite the stock’s price challenges, Deccan Health Care has reported positive results for the last three consecutive quarters. The company’s operating cash flow for the year reached its highest level at Rs. -6.43 crores, while net sales for the latest six-month period stood at Rs.43.54 crores, representing growth of 28.51%. The inventory turnover ratio for the half-year was recorded at 1.84 times, the highest in recent periods, suggesting improved efficiency in managing stock levels.
Valuation metrics indicate the stock is trading at a price-to-book value of 0.3, which is lower than the average historical valuations of its peers. This discount reflects the market’s cautious stance on the company’s prospects amid its financial and price performance.
Is Deccan Health Care your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Shareholding and Market Capitalisation
The majority of Deccan Health Care’s shares are held by non-institutional investors, indicating a shareholder base dominated by retail or private investors rather than large financial institutions. The company’s market capitalisation grade is rated at 4, reflecting its relative size within the market.
While the stock’s recent day change was a decline of 0.41%, this movement is part of a broader trend of subdued price action. The stock’s persistent trading below all major moving averages and its sustained underperformance relative to sector and benchmark indices highlight ongoing challenges in regaining investor confidence.
Summary of Key Price and Performance Data
To summarise, Deccan Health Care’s stock has reached Rs.14.2, its lowest level in 52 weeks and all time, following a four-day losing streak. The stock’s year-on-year return of -51.63% contrasts sharply with the Sensex’s positive 4.03% return. The company’s financial indicators show modest profitability and limited debt servicing capacity, while recent sales growth and operational cash flow figures provide some context to its current valuation.
These factors collectively illustrate the stock’s current position within the healthcare services sector and the broader market environment as of December 2025.
Get 1 year of Weekly Picks FREE when you subscribe to MojoOne. Offer ends soon. Start Saving Now →
